Clinical Trials Directory

Trials / Completed

CompletedNCT01664689

Intraoperative and Postoperative Outcomes of Three Ophthalmic Viscosurgical Devices During Phacoemulsification

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Iladevi Cataract and IOL Research Center · Academic / Other
Sex
All
Age
45 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Ophthalmic Viscosurgical Devices (OVDs) play a crucial role during phacoemulsification, by providing endothelial protection, maintaining space, as well as facilitating surgical maneuvers, including IOL implantation. Equally important is the ease of use, good visualisation and easy removal of the OVD from the eye. Currently, 3 popularly used OVDs as a single injection sufficing for surgery are: Healon 5, DiscoVisc, and Celoftal (2% hydroxypropylmethylcellulose). Whereas, there are studies showing efficacy of each of these in clinical scenarios, there is no randomized trial comparing intraoperative performance and postoperative outcomes. The aim of this study was to compare intraoperative performance and postoperative outcomes following microcoaxial phacoemulsification when using one of the three OVDs

Conditions

Interventions

TypeNameDescription
PROCEDUREMicrocoaxial Phacoemulsification

Timeline

Start date
2011-10-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2012-08-14
Last updated
2012-08-14

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01664689. Inclusion in this directory is not an endorsement.